Doctors are finally learning to manage antidepressant withdrawal

For decades, antidepressants have become a common treatment for depression and anxiety, with selective serotonin reuptake inhibitors (SSRIs) leading the way. Though initially effective, many individuals struggle when they attempt to stop taking these medications. Mark Horowitz, a former medical student, experienced intense withdrawal symptoms after reducing his dose of escitalopram, a common SSRI.

These symptoms included panic attacks, dizziness, and insomnia, which were reportedly more severe than the depression that initially prompted him to start on the medication.

Horowitz's experience mirrors that of many others who have struggled with antidepressant withdrawal, prompting a growing conversation about the safety and long-term effects of these drugs. While SSRIs are touted as relatively safe compared to older antidepressants, recent research suggests that their long-term use may carry significant risks.

A survey published last year revealed that nearly three-quarters of UK patients taking SSRIs felt they were helpful, although this figure may be influenced by the placebo effect. Additionally, a 2024 analysis of over 670,000 individuals with depression found the drugs to have small to moderate effectiveness.

However, the guidelines for managing antidepressant withdrawal have been lacking. A 2022 study found that none of the national health authorities' clinical practice guidelines provided specific instructions on tapering doses or managing withdrawal symptoms. This oversight has left many patients, like Horowitz, to navigate the withdrawal process on their own, often leading to severe psychological difficulties that are misinterpreted as recurrences of the original condition.

This, in turn, can result in patients being re-prescribed antidepressants, perpetuating a cycle of dependency.

Experts argue that the long-term risks of SSRIs are still largely unknown, as clinical trials for these medications typically last only eight weeks. This limited timeframe makes it challenging to fully understand the full spectrum of side effects and withdrawal symptoms associated with long-term use. As a result, many are questioning whether the benefits of SSRIs have been overstated and whether society has become overly reliant on these medications as a treatment for mental health challenges.